Whats New

Buccal Delivery

Utilisation of this technology for different pharmaceutical applications, with commercial partners continues - Q1 to Q4 2011.

Colon Health

Utilisation of this technology for different pharmaceutical applications, with commercial partners continues - Q1 to Q4 2011.

New round of clinical trials to manage diarrhoea initiated Q3 2011.

Encapsulation/Taste Masking/Drug and Nutrient Delivery/Controlled Release

Developments progressing with different partners (food, feed and pharma) within this field.

GORD (GERD)

Utilisation of this technology for specific pharmaceutical applications, with commercial partner continues - Q1 to Q4 2011.

Hypoglycaemia Management

Utilisation of this technology for specific pharmaceutical applications, with commercial partners continues - Q1 to Q4 2011 - in the fields of (i) consumer nutrition; (ii) in-born errors of metabolism and (iii) diabetes. Other applications of the technology are under development.

Products are on the market within these fields.

Satiety

Utilisation of this technology for specific pharmaceutical applications, with commercial partner initiated Q3 to Q4 2011.

Skin Care

Utilisation of this technology for specific pharmaceutical applications, with commercial partner continues - Q1 to Q4 2011.

Vaginal Health

Utilisation of this technology for specific pharmaceutical applications, with commercial partners continues - Q1 to Q4 2011.

Heparin Analogues

Technology under development.

Wound Care

The Company has two interests within this area:

• Diagnostics
• Dressings

Both areas continue to develop with relevant partners.

Diagnostic Kits

Kits are now on the market with relevant partners (under licence).